drugset / Trial / NCT01864551

Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder

NCT01864551

Phase 4 Completed 60 enrolled Tri-Service General Hospital (TSGH)
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The investigators hypothesized that olanzapine will be superior to lamotrigine in the prevention of any kind of recurrence of bipolar disorder. On the other hand, lamotrigine group will have better prevention of depressive episode than olanzapine group. Meanwhile, the investigators supposed that there will be more concomitant medicine in lamictal group than olanzapine group. The comorbidity will influence the measurement of outcome such as time period of recurrence of depressive episode in both groups..

Timeline

Start
2008-08
Primary completion
2009-07
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lamotrigine Small molecule
Comparator Olanzapine Small molecule

Indications